中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

自发性细菌性腹膜炎的分子诊断研究进展

吴浩馨 胡中杰

引用本文:
Citation:

自发性细菌性腹膜炎的分子诊断研究进展

DOI: 10.3969/j.issn.1001-5256.2022.01.042
基金项目: 

北京市肝病研究所基金 (Y-2021YS-1)

利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:吴浩馨负责文献检索和论文撰写;胡中杰负责论文审校。
详细信息
    通信作者:

    胡中杰,huzhongjie@ccmu.edu.cn

Research advances in the molecular diagnosis of spontaneous bacterial peritonitis

Research funding: 

Beijing Institute of Hepatology Foundation (Y-2021YS-1)

  • 摘要: 自发性细菌性腹膜炎(SBP)是终末期肝病最常见的感染类型,SBP的诊断和治疗面临着很大的困难和挑战。近些年来,分子诊断技术尽管获得了极大的进步,但未广泛应用于临床实践。本文根据SBP的诊断现状,综述分子微生物诊断方法在SBP诊断上的进展,单纯细菌定性并不能明确细菌DNA与临床表现的关系,细菌定量结合其类型更能准确描述SBP的生物学特征,可为SBP及其特殊类型的诊断和指导抗菌药物的应用提供可能。

     

  • [1] MARCIANO S, DÍAZ JM, DIRCHWOLF M, et al. Spontaneous bacterial peritonitis in patients with cirrhosis: Incidence, outcomes, and treatment strategies[J]. Hepat Med, 2019, 11: 13-22. DOI: 10.2147/HMER.S164250.
    [2] SHIZUMA T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review[J]. World J Hepatol, 2018, 10(2): 254-266. DOI: 10.4254/wjh.v10.i2.254.
    [3] Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.

    中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
    [4] AITHAL GP, PALANIYAPPAN N, CHINA L, et al. Guidelines on the management of ascites in cirrhosis[J]. Gut, 2021, 70(1): 9-29. DOI: 10.1136/gutjnl-2020-321790.
    [5] COBURN B, MORRIS AM, TOMLINSON G, et al. Does this adult patient with suspected bacteremia require blood cultures?[J]. JAMA, 2012, 308(5): 502-511. DOI: 10.1001/jama.2012.8262.
    [6] POTGIETER M, BESTER J, KELL DB, et al. The dormant blood microbiome in chronic, inflammatory diseases[J]. FEMS Microbiol Rev, 2015, 39(4): 567-591. DOI: 10.1093/femsre/fuv013.
    [7] European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2): 406-460. DOI: 10.1016/j.jhep.2018.03.024.
    [8] ENOMOTO H, INOUE SI, MATSUHISA A, et al. Amplification of bacterial genomic DNA from all ascitic fluids with a highly sensitive polymerase chain reaction[J]. Mol Med Rep, 2018, 18(2): 2117-2123. DOI: 10.3892/mmr.2018.9159.
    [9] YOO IY, KANG OK, LEE MK, et al. Comparison of 16S ribosomal RNA targeted sequencing and culture for bacterial identification in normally sterile body fluid samples: Report of a 10-year clinical laboratory review[J]. Ann Lab Med, 2020, 40(1): 63-67. DOI: 10.3343/alm.2020.40.1.63.
    [10] BERG RD. Bacterial translocation from the gastrointestinal tract[J]. J Med, 1992, 23(3-4): 217-244. https://pubmed.ncbi.nlm.nih.gov/10659341/
    [11] SUCH J, FRANCÉS R, MUÑOZ C, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites[J]. Hepatology, 2002, 36(1): 135-141. DOI: 10.1053/jhep.2002.33715.
    [12] GUARNER C, GONZÁLEZ-NAVAJAS JM, SÁNCHEZ E, et al. The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation[J]. Hepatology, 2006, 44(3): 633-639. DOI: 10.1002/hep.21286.
    [13] AMAR Y, LAGKOUVARDOS I, SILVA RL, et al. Pre-digest of unprotected DNA by Benzonase improves the representation of living skin bacteria and efficiently depletes host DNA[J]. Microbiome, 2021, 9(1): 123. DOI: 10.1186/s40168-021-01067-0.
    [14] ZAPATER P, FRANCÉS R, GONZÁLEZ-NAVAJAS JM, et al. Serum and ascitic fluid bacterial DNA: A new independent prognostic factor in noninfected patients with cirrhosis[J]. Hepatology, 2008, 48(6): 1924-1931. DOI: 10.1002/hep.22564.
    [15] BRUNS T, REUKEN PA, STENGEL S, et al. The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection[J]. Liver Int, 2016, 36(8): 1133-1142. DOI: 10.1111/liv.13095.
    [16] TREBICKA J, BORK P, KRAG A, et al. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 167-180. DOI: 10.1038/s41575-020-00376-3.
    [17] STENGEL S, QUICKERT S, LUTZ P, et al. Peritoneal level of CD206 associates with mortality and an inflammatory macrophage phenotype in patients with decompensated cirrhosis and spontaneous bacterial peritonitis[J]. Gastroenterology, 2020, 158(6): 1745-1761. DOI: 10.1053/j.gastro.2020.01.029.
    [18] KROHN S, BÖHM S, ENGELMANN C, et al. Application of qualitative and quantitative real-time PCR, direct sequencing, and terminal restriction fragment length polymorphism analysis for detection and identification of polymicrobial 16S rRNA genes in ascites[J]. J Clin Microbiol, 2014, 52(5): 1754-1757. DOI: 10.1128/JCM.00552-14.
    [19] ALVAREZ-SILVA C, SCHIERWAGEN R, POHLMANN A, et al. Compartmentalization of immune response and microbial translocation in decompensated cirrhosis[J]. Front Immunol, 2019, 10: 69. DOI: 10.3389/fimmu.2019.00069.
    [20] FAGAN KJ, ROGERS GB, MELINO M, et al. Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection[J]. PLoS One, 2015, 10(3): e0120642. DOI: 10.1371/journal.pone.0120642.
    [21] BARTOLETTI M, GIANNELLA M, LEWIS RE, et al. Bloodstream infections in patients with liver cirrhosis[J]. Virulence, 2016, 7(3): 309-319. DOI: 10.1080/21505594.2016.1141162.
    [22] YANG TY, ZHANG M. The bacterial distribution and antibiotic resistance analysis of 258 cases of positive sample results from ascites bacterial culture[J]. Labeled Immunoassays & Clin Med, 2019, 26(9): 1493-1497, 1523. DOI: 10.11748/bjmy.issn.1006-1703.2019.09.011.

    杨添尹, 张曼. 258例腹水培养阳性结果的细菌学分布及耐药性分析[J]. 标记免疫分析与临床, 2019, 26(9): 1493-1497, 1523. DOI: 10.11748/bjmy.issn.1006-1703.2019.09.011.
    [23] CHEN Y, GUO J, SHI D, et al. Ascitic bacterial composition is associated with clinical outcomes in cirrhotic patients with culture-negative and non-neutrocytic ascites[J]. Front Cell Infect Microbiol, 2018, 8: 420. DOI: 10.3389/fcimb.2018.00420.
    [24] HADERER M, NEUBERT P, RINNER E, et al. Novel pathomechanism for spontaneous bacterial peritonitis: Disruption of cell junctions by cellular and bacterial proteases[J]. Gut, 2021. DOI: 10.1136/gutjnl-2020-321663.[Epub ahead of print].
    [25] PIANO S, SINGH V, CARACENI P, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide[J]. Gastroenterology, 2019, 156(5): 1368-1380. e10. DOI: 10.1053/j.gastro.2018.12.005.
    [26] FERNÁNDEZ J, PRADO V, TREBICKA J, et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe[J]. J Hepatol, 2019, 70(3): 398-411. DOI: 10.1016/j.jhep.2018.10.027.
    [27] SORIANO G, ESPARCIA O, MONTEMAYOR M, et al. Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis[J]. Aliment Pharmacol Ther, 2011, 33(2): 275-284. DOI: 10.1111/j.1365-2036.2010.04506.x.
    [28] GU W, DENG X, LEE M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids[J]. Nat Med, 2021, 27(1): 115-124. DOI: 10.1038/s41591-020-1105-z.
  • 加载中
计量
  • 文章访问数:  400
  • HTML全文浏览量:  106
  • PDF下载量:  65
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-06-05
  • 录用日期:  2021-06-28
  • 出版日期:  2022-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回